Susquehanna International Group
CLOV icon

Susquehanna International Group’s Clover Health Investments CLOV Stock Holding History

Susquehanna International Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Sell
1,273,000
-1,245,500
-49% -$2.7M ﹤0.01% 5908
2025
Q4 		$5.92M Buy
2,518,500
+617,400
+32% +$1.69M ﹤0.01% 3762
2025
Q3 		$5.82M Buy
1,901,100
+835,100
+78% +$2.39M ﹤0.01% 3838
2025
Q2 		$2.97M Buy
1,066,000
+50,500
+5% +$166K ﹤0.01% 4975
2025
Q1 		$3.65M Sell
1,015,500
-402,000
-28% -$1.61M ﹤0.01% 4265
2024
Q4 		$4.47M Buy
1,417,500
+176,100
+14% +$629K ﹤0.01% 3782
2024
Q3 		$3.5M Buy
1,241,400
+484,800
+64% +$1.11M ﹤0.01% 4261
2024
Q2 		$931K Buy
756,600
+185,900
+33% +$167K ﹤0.01% 6763
2024
Q1 		$451K Sell
570,700
-40,000
-7% -$36.4K ﹤0.01% 8748
2023
Q4 		$580K Sell
610,700
-404,000
-40% -$397K ﹤0.01% 8294
2023
Q3 		$1.1M Buy
1,014,700
+327,800
+48% +$390K ﹤0.01% 6430
2023
Q2 		$618K Sell
686,900
-82,800
-11% -$73.4K ﹤0.01% 7813
2023
Q1 		$654K Buy
769,700
+115,300
+18% +$126K ﹤0.01% 7903
2022
Q4 		$609K Sell
654,400
-741,000
-53% -$989K ﹤0.01% 7351
2022
Q3 		$2.37M Sell
1,395,400
-242,200
-15% -$634K ﹤0.01% 4587
2022
Q2 		$3.5M Sell
1,637,600
-356,000
-18% -$946K ﹤0.01% 3799
2022
Q1 		$7.08M Sell
1,993,600
-1,666,700
-46% -$4.83M ﹤0.01% 3070
2021
Q4 		$13.6M Sell
3,660,300
-1,575,100
-30% -$9.66M ﹤0.01% 2294
2021
Q3 		$38.7M Buy
5,235,400
+446,800
+9% +$3.82M 0.01% 1350
2021
Q2 		$63.8M Buy
4,788,600
+3,527,700
+280% +$34.6M 0.01% 1030
2021
Q1 		$9.53M Buy
1,260,900
+87,000
+7% +$982K ﹤0.01% 2846
2020
Q4 		$19.7M Buy
+1,173,900
New +$13.1M ﹤0.01% 1755

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group's CLOV Position: Q1 2026 in Review

Susquehanna International Group reduced its Clover Health Investments (CLOV) stake by 61% in Q1 2026, selling an estimated $3.09M and leaving 898,557 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #6728.

Susquehanna International Group first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $45.1M in Q3 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Susquehanna International Group held 898,557 shares of Clover Health Investments worth $1.58M as of Q1 2026.
  • Susquehanna International Group sold 1,426,696 Clover Health Investments shares in Q1 2026, an estimated $3.09M.
  • Clover Health Investments made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6728 holding.
  • Susquehanna International Group first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Clover Health Investments position peaked at $45.1M in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.